Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of ...

Progression-free survival (PFS) in intermediate-stage hepatocellular carcinoma (HCC) improved by almost 5 months when a ...

A novel liver-on-a-chip model can be used to study immune cell interactions in liver cancer and test promising new therapies.

A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...

A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

Sugary Drinks , Linked to High Risk of Liver Cancer, , Study Finds. The study was conducted by researchers with several ...

Patients with intermediate-stage liver cancer may benefit from receiving a Lenvima-Keytruda combination with transarterial ...

After a surprise failure in advanced liver cancer, Merck & Co. and Eisai are hoping new data can make their Keytruda-Lenvima combination a standard of care in intermediate-stage disease. | After a ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP ...

Throughout the McFarland’s ordeal, the Children’s Cancer Network became the family’s ally.